Key result
A review of venous thromboembolism management in pregnancy highlights significant practice variation and limited data regarding postpartum low-molecular-weight heparin and peripartum anticoagulation.
Why the study?
Practice variation exists in the prevention and management of VTE in pregnancy, driven by limited data and differing recommendations across major guidelines.
Design
Review
Authors
Loading...
Clinical practice in peripartum VTE management remains variable; leaves open optimal LMWH strategies pending prospective trials.
This review highlights the clinical practice variation and limited data regarding VTE prevention and management in pregnancy, particularly concerning postpartum LMWH use and peripartum anticoagulation.
Leslie Skeith (2021) conducted a review in Venous thromboembolism in pregnancy. Low-molecular-weight heparin (LMWH) and anticoagulation management was evaluated. A review of venous thromboembolism management in pregnancy highlights significant practice variation and limited data regarding postpartum low-molecular-weight heparin and peripartum anticoagulation.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: